News

Revenue Growth: DexCom's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 12.49%.
Saluda Medical announced that it appointed Barry Regan as its new president and CEO, effective July 14, 2025. Regan most ...
Analyst Price Forecast Suggests 22.56% Upside As of June 1, 2025, the average one-year price target for DexCom is $101.72/share. The forecasts range from a low of $82.82 to a high of $120.75.
DexCom’s product pipeline remains robust, with several innovations poised to drive future growth. The company recently received approval for its G7 15-Day CGM system, which is expected to launch ...
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products ...
Mr Ralph Roland, the Chairman of the State Housing Company Limited Board, pledged to restore the company with his team, to its central role in Ghana’s development. With boldness, integrity and ...
1 Dexcom State of Type 2 Report (US), Dexcom data on file, 2025. 2 Blake CL, et al. “Reduced Mortality Risk Associated with Dexcom rtCGM Compared to SMBG Among People with T2D on Any Insulin ...
Agros Progress Development Public Ltd, parent company of the Rodon hotel, held its annual general meeting (AGM) on Thursday, during which shareholders approved a dividend distribution and made ...
After a yearslong legal battle, the Plum Zoning Hearing Board rejected the application for a second injection well in the borough, which is an about-face from its initial decision. Board member ...
Liberty Mutual Insurance Chairman and Chief Executive Officer (CEO) Tim Sweeney today announced that Gordon Watson, formerly the Chair of AXA Asia and CEO of AXA Asia & Africa, has been elected to ...
Dexcom, A Top 3% Stock, Raises 2025 Outlook Amid 'Rapidly' Expanding Diabetes Market Dexcom's revenue could reach $5 billion in 2025, the company said Friday as it announced a new CGM device.